China News Service, Beijing, June 28 (Chen Hang) From June 25, the price of nucleic acid testing in public medical institutions in Beijing has been reduced from 180 yuan to 120 yuan each time. This price is the highest government guide price, and medical institutions must not rise However, it can be adjusted according to its own situation, and the range of float is not limited.
Du Xin, deputy director of the Beijing Municipal Medical Security Bureau and spokesman for the news, mentioned the above at the press conference on the 28th.
Recently, in order to further reduce the cost of accounting and testing and the cost burden of the public, in conjunction with changes in the price of testing reagents, the Beijing Medical Security Bureau, together with the health and financial departments, adjusted the price of nucleic acid testing projects. From June 25, the city’s public medical institutions The price of nucleic acid testing is reduced from 180 yuan to 120 yuan each time. This price is the highest government guide price. Medical institutions may not float up, but they can be adjusted according to their own circumstances.
Non-public medical insurance designated medical institutions also implement the above policies when providing nucleic acid detection services for insured persons.
Non-public non-medical insurance designated medical institutions (such as third-party testing institutions, non-medical insurance designated private hospitals, etc.) implement market-regulated price management in accordance with relevant national and municipal regulations, and testing prices are set independently by the institutions.
For the "exhaustive inspection" population specified by Beijing, if the government entrusts a third-party inspection agency to undertake the inspection task, the government funds shall be guaranteed according to the agreed standards.
In addition, for those who are willing to perform exhaustive inspections, those who conduct nucleic acid testing in public medical institutions shall pay the test fee at their own expense in accordance with the government-guided price standard; if they perform nucleic acid testing in third-party testing institutions, they shall follow the independent pricing standards of third-party institutions. Individual pays for testing costs.
Du Xin said that he will pay close attention to the implementation of the nucleic acid detection price policy and cooperate with the market supervision department to do a good job in supervision. At the same time, based on the latest national and Beijing requirements, the development of nucleic acid detection technology and related cost changes, etc., the price of the test is dynamically adjusted to help the city's epidemic prevention and control work.
From the beginning of the epidemic, the Beijing Municipal Medical Security Bureau will temporarily include suspected and diagnosed new coronary pneumonia patients detection and treatment related drugs, medical service items, etc. into the scope of medical insurance reimbursement in accordance with national requirements. Patients do not affect treatment due to cost issues.
With the development of the epidemic prevention and control situation, from May 19, the Beijing Medical Security Bureau negotiated with the municipal finance bureau and other relevant departments to further include the "examineable" population prescribed by the state and this city into the scope of protection. If the designated medical institution of the medical insurance carries out the nucleic acid test, it shall be reimbursed according to the regulations, and the personal burden shall be borne by the two levels of urban finance. (Finish)